Stem cells are a group of cells that do not differentiate into specialized cells. All these stem cells originate from a single cell. Stem cells can undergo differentiation continuously, as they do not form any specialized cells. There are two types of stem cells, multipotent and pluripotent. Pluripotent stem cells are derived from the embryo and they facilitate the growth of cells in three germ layers. Stem cell therapy is also called regenerative medicine. This is a group of therapies which can regenerate organs, tissue or cells in humans and aid in restoring the normal functioning of organs. These stem cell therapies can be used for treating sickle cell disease, spinal cord injury, heart diseases, Parkinson’s disease and diabetes.
Global stem cell therapy market was valued at US$ 7,313.6 Mn in 2018, and is expected to exhibit a CAGR of 21.1% over the forecast period.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/2848
Riding uses of stem cells for treating spinal cord injury, cancers or other diseases is estimated to augment growth of the global stem cell therapy market during the forecast period. For instance, in 2016, the National Spinal Cord Injury Statistical Center, stated that in the United States of America, 17,000 cases of spinal cord injury are recorder every year. Furthermore, in 2017, the Leukemia and Lymphoma Society mentioned that 172,910 individuals were suffering from lymphoma and leukemia in the United States of America, which caused an increase in adoption of stem cell therapy for their treatment. Moreover, rising product launches by key players is anticipated to fuel growth of the global stem cell therapy market during the forecast period. For instance, mTeSR Plus was launched by STEMCELL Technologies, in January 2019. This is a human pluripotent stem cell (hPSC) maintenance medium which prevents growth arrest, genomic instability and DNA damage. Rising research and developmental activities and clinical trials of induced pluripotent stem cells is anticipated to propel growth of the global stem cell therapy market during the forecast period. For instance, Fate Therapeutics collaborated with researchers from UC San Diego for launching Off-the-shelf immunotherapy, which was developed from induced pluripotent stem cells in humans. This therapy is still under clinical trials.
North America is anticipated to witness a robust growth in the global stem cell therapy market over the forecast period, due to rising number of clinical trials for catering the medical needs of patients. For instance, UCLA-UCI Alpha Stem Cell Clinic carried out a clinical research in April, 2019, for examining CTX0E03 DP, a stem cell product. This product would help in improving functions in individuals having chronic disability due to ischemic stroke, the study is in phase IIb of clinical study. Furthermore, manufacturers are focusing on expanding the potential of stem cells present in newborns, which is estimated to fuel growth of the global stem cell therapy market, during the forecast period. For instance, the Institute of Integrative Biology and Anika Therapeutics, Inc., collaborated for developing an injectable mesenchymal stem cell therapy for treating osteoarthritis in individuals.
Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2848
- The global stem cell therapy market is anticipated to exhibit a CAGR of 21.1% during the forecast period, due to rising adoption of stem cell therapy and acquisitions and collaborations by key players. For instance, Metrion Biosciences Ltd. and Axiogenesis AG collaborated in 2016, for optimizing, validating and commercializing induced pluripotent stem cell-derived cells and tissues.
- Adult stem cells segment, among cell source in the global stem cell therapy market is expected to witness growth during the forecast period, due to adoption of strategies like collaborations and partnerships by key players. For instance, RoosterBio Inc., and Pall Corporation announced their partnership in October 2016. The main aim of this partnership was to expand their large-scale bioreactors of human stromal cells for accelerating the product development and commercialization of stem cell based therapies.
- North America is estimated to witness robust growth in the global stem cell therapy market over the forecast period, due to increasing incidences of cancer. For instance, the National Cancer Institute, mentioned that 1,685,210 new cases were reported in United States of America in 2016.
- Key players active in the global stem cell therapy market are Stemedica Cell Technologies, Inc, Magellan, Pharmicell Co., Inc., Medipost Co., Ltd, Kolon TissueGene, Inc., Anterogen Co. Ltd., Osiris Therapeutics, Inc. and JCR Pharmaceuticals Co., Ltd.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Stem Cell Therapy Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Stem Cell Therapy Industry Impact
Chapter 2 Global Stem Cell Therapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Stem Cell Therapy (Volume and Value) by Type
2.3 Global Stem Cell Therapy (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Stem Cell Therapy Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Stem Cell Therapy Market Analysis
Chapter 6 East Asia Stem Cell Therapy Market Analysis
Chapter 7 Europe Stem Cell Therapy Market Analysis
Chapter 8 South Asia Stem Cell Therapy Market Analysis
Chapter 9 Southeast Asia Stem Cell Therapy Market Analysis
Chapter 10 Middle East Stem Cell Therapy Market Analysis
Chapter 11 Africa Stem Cell Therapy Market Analysis
Chapter 12 Oceania Stem Cell Therapy Market Analysis
Chapter 13 South America Stem Cell Therapy Market Analysis
Chapter 14 Company Profiles and Key Figures in Stem Cell Therapy Business
Chapter 15 Global Stem Cell Therapy Market Forecast (2022-2028)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/2848
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027